Advisors Asset Management’s PIMCO Enhanced Low Duration Active Exchange-Traded Fund LDUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-685
Closed -$69K 1519
2021
Q4
$69K Sell
685
-507
-43% -$51.3K ﹤0.01% 1410
2021
Q3
$121K Sell
1,192
-34
-3% -$3.46K ﹤0.01% 1285
2021
Q2
$125K Sell
1,226
-8
-0.6% -$815 ﹤0.01% 1278
2021
Q1
$126K Buy
1,234
+211
+21% +$21.5K ﹤0.01% 1301
2020
Q4
$104K Buy
1,023
+602
+143% +$61.4K ﹤0.01% 1354
2020
Q3
$43K Buy
+421
New +$42.9K ﹤0.01% 1424
2019
Q2
Sell
-168
Closed -$17K 1577
2019
Q1
$17K Sell
168
-34
-17% -$3.37K ﹤0.01% 1714
2018
Q4
$20K Sell
202
-4
-2% -$397 ﹤0.01% 1511
2018
Q3
$21K Sell
206
-1
-0.5% -$100 ﹤0.01% 1511
2018
Q2
$21K Buy
207
+113
+120% +$11.3K ﹤0.01% 1506
2018
Q1
$9K Buy
+94
New +$9.4K ﹤0.01% 1461

Other funds holding LDUR

Advisors Asset Management's LDUR Position: Q1 2022 in Review

Advisors Asset Management sold out of PIMCO Enhanced Low Duration Active Exchange-Traded Fund (LDUR) in Q1 2022, closing a stake of 685 shares — an estimated $69K sold.

Advisors Asset Management first reported a position in LDUR in Q1 2018 and held it in 11 quarters. The position peaked at $126K in Q1 2021. 143 funds tracked by Wall St. Rank hold LDUR as of Q1 2022.

  • Advisors Asset Management reported no remaining PIMCO Enhanced Low Duration Active Exchange-Traded Fund position as of Q1 2022 after selling out during the quarter.
  • Advisors Asset Management sold 685 PIMCO Enhanced Low Duration Active Exchange-Traded Fund shares in Q1 2022, an estimated $69K.
  • Advisors Asset Management first reported a position in PIMCO Enhanced Low Duration Active Exchange-Traded Fund in Q1 2018 and held it in 11 quarters.
  • Advisors Asset Management's PIMCO Enhanced Low Duration Active Exchange-Traded Fund position peaked at $126K in Q1 2021.
  • 143 funds tracked by Wall St. Rank held PIMCO Enhanced Low Duration Active Exchange-Traded Fund as of Q1 2022.

Based on Advisors Asset Management's 13F filing for Q1 2022, filed 17 May 2022.